BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 7474110)

  • 1. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells.
    Heinkelein M; Sopper S; Jassoy C
    J Virol; 1995 Nov; 69(11):6925-31. PubMed ID: 7474110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells.
    Nardelli B; Gonzalez CJ; Schechter M; Valentine FT
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7312-6. PubMed ID: 7638187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization.
    Ugolini S; Mondor I; Parren PW; Burton DR; Tilley SA; Klasse PJ; Sattentau QJ
    J Exp Med; 1997 Oct; 186(8):1287-98. PubMed ID: 9334368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
    Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus glycoprotein-specific CD4+ cytotoxic T lymphocytes are involved in two types of cytotoxicity: antigen-specific and cell-cell fusion-related cell lysis.
    Ehret R; Heinkelein M; Siliciano RF; Jassoy C
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):1017-21. PubMed ID: 9264288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type-1 envelope glycoprotein gp120 induces expression of fusion regulatory protein (FRP)-1/CD98 on CD4+ T cells: a possible regulatory mechanism of HIV-induced syncytium formation.
    Suga S; Tsurudome M; Ito M; Ohgimoto S; Tabata N; Nishio M; Kawano M; Komada H; Ito M; Sakurai M; Ito Y
    Med Microbiol Immunol; 1997 Mar; 185(4):237-43. PubMed ID: 9138296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
    Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
    Golding B; Inman J; Highet P; Blackburn R; Manischewitz J; Blyveis N; Angus RD; Golding H
    J Virol; 1995 Jun; 69(6):3299-307. PubMed ID: 7745677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression.
    Yin C; Wu MS; Pauza CD; Salvato MS
    J Virol; 1999 May; 73(5):3692-701. PubMed ID: 10196261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
    Ollerton MT; Berger EA; Connick E; Burton GF
    J Virol; 2020 May; 94(10):. PubMed ID: 32161179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
    Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
    J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.
    Gorse GJ; Simionescu RE; Patel GB
    Clin Vaccine Immunol; 2006 Jan; 13(1):26-32. PubMed ID: 16425996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Celada F; Düzgüneş N
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity.
    Richard J; Veillette M; Ding S; Zoubchenok D; Alsahafi N; Coutu M; Brassard N; Park J; Courter JR; Melillo B; Smith AB; Shaw GM; Hahn BH; Sodroski J; Kaufmann DE; Finzi A
    EBioMedicine; 2016 Jan; 3():122-134. PubMed ID: 26870823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivo.
    Crowe SM; Mills J; Elbeik T; Lifson JD; Kosek J; Marshall JA; Engleman EG; McGrath MS
    Clin Immunol Immunopathol; 1992 Nov; 65(2):143-51. PubMed ID: 1356673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
    Chowdhury MI; Koyanagi Y; Suzuki M; Kobayashi S; Yamaguchi K; Yamamoto N
    Virus Genes; 1992 Jan; 6(1):63-78. PubMed ID: 1347963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.
    Grant MD; Smaill FM; Rosenthal KL
    Clin Exp Immunol; 1993 Sep; 93(3):356-62. PubMed ID: 8103717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.